Boehringer Ingelheim receives approval for Senvelgo in Europe for diabetic cats
Ingelheim: Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO (active ingredient: velagliflozin), marking a significant step for the treatment of ...
Read more
